Category: Innovation Ecosystem

Capital Is Becoming More Selective and More Strategic

One theme surfacing consistently across investor conversations is increased selectivity around commercialization readiness, operational planning, and capital efficiency.

Investors continue to support early-stage innovation, but expectations around traction and execution have increased significantly over the past several years.

For founders, this means:

• Greater focus on milestones and capital deployment
• Longer timelines to close funding rounds
• Increased scrutiny around commercialization strategy and operational readiness

This shift is influencing both clean technology and advanced materials startups, particularly those navigating longer development timelines or more capital-intensive scale-up requirements.

Increasingly, investors are looking for evidence that companies understand not just the science, but the path to manufacturing, partnerships, and market adoption.

Several founders have also described increasing pressure to think about manufacturing strategy and operational readiness much earlier in fundraising conversations than they would have several years ago.

These commercialization and scale-up questions are increasingly shaping conversations heading into IS:CleanTech this year.

Non-Dilutive Funding Is Playing a Larger Role

One theme surfacing consistently across investor conversations is increased selectivity around commercialization. As venture capital becomes more selective, many early-stage companies are turning to grants and government programs that support development without requiring founders to give up equity.

These funding sources can help companies:

• Test and refine technologies before larger investment rounds
• Extend runway between financings
• Build technical validation and early momentum

Rather than relying on a single source of capital, many founders are combining:

• Non-dilutive grants
• Strategic partnerships
• Targeted equity investment

This blended approach is becoming increasingly important for companies developing technologies that require longer commercialization timelines, pilot validation, or manufacturing scale-up.

For many science-based startups, the challenge is no longer simply raising capital. It is sequencing the right types of capital at the right stages of growth.

Corporate Partnerships Are Accelerating Commercialization

Another theme emerging more consistently across the ecosystem is the growing role of partnerships in helping companies move technologies toward commercialization.

Increasingly, startups, corporations, universities, and public-sector organizations are working together earlier in the commercialization process to help companies navigate technical validation, manufacturing readiness, pilot development, and scale-up.

At The Innovation Space, collaboration with strategic partners including DuPont, IFF, the University of Delaware, and the State of Delaware helps connect founders with industry expertise, infrastructure, research capabilities, and commercialization support that can help advance progress toward market adoption.

For many clean technology and advanced materials startups, those connections are becoming increasingly important as commercialization pathways grow more complex and capital-intensive.

Corporations are also engaging with startups in more diverse ways than in the past, including as:

• Pilot partners
• Development collaborators
• Strategic investors
• Early commercial customers

In many cases, these relationships can help companies validate technologies in real-world conditions earlier in development and better understand operational requirements before scale-up.

The Focus Is Shifting From Breakthrough to Scale

Scientific innovation remains the foundation of clean technology and advanced materials development. But increasingly, the central challenge is execution.

Questions shaping commercialization conversations today include:

• Can the technology be manufactured at scale?
• Does it perform reliably outside the lab?
• Can production processes support commercial adoption?
• How early should pilot and manufacturing planning begin?

This shift is changing how companies approach development:

• Earlier investment in pilot and demonstration projects
• Greater attention to manufacturing readiness and operational planning
• More cross-functional teams that bridge science, engineering, operations, and business strategy

For many startups, the transition from prototype to pilot is the stage that determines whether a technology can move beyond the lab.

This is particularly true for advanced materials companies, where scale-up often introduces entirely new technical and operational challenges not visible during early R&D.

Several companies across the ecosystem are also navigating increasing pressure to demonstrate operational readiness alongside technical validation much earlier in commercialization discussions.

Getting that transition right increasingly depends on access to infrastructure, commercialization expertise, manufacturing insight, and the right ecosystem connections.

Ecosystems Are Becoming a Competitive Advantage

Clean technology and advanced materials companies do not scale in isolation.

As technologies move closer to commercialization, access to the right environment increasingly shapes what companies can achieve. That includes:

• Specialized lab space
• Shared scientific equipment
• Industry and academic partnerships
• Commercialization guidance
• Access to investors and pilot opportunities

Regional ecosystems built through collaboration between industry, academia, and public-sector organizations are playing a growing role in reducing barriers to scale.

In Delaware, long-standing collaboration between industry, academia, and public-sector partners has helped create an environment where startups can access technical expertise, infrastructure, commercialization support, research capabilities, and industry relationships within a connected ecosystem.

Partnerships involving organizations like DuPont, IFF, the University of Delaware, and the State of Delaware further strengthen those connections, particularly for founders navigating manufacturing, specialty chemistry, industrial validation, scale-up, and commercialization planning.

Many of the commercialization and scale-up challenges facing clean technology startups are equally relevant to advanced materials companies, particularly those navigating manufacturing readiness, specialty chemistry, industrial validation, and supply chain complexity.

That overlap is one reason conversations at IS:CleanTech increasingly extend beyond traditional clean technology into advanced materials and industrial innovation more broadly.

For founders, where they build is becoming a strategic decision that influences access to infrastructure, talent, partnerships, and long-term growth opportunities.

What We Offer

Lab Space & Equipment

Innovation Space offers 130,000 sq ft with 90+ labs, state-of-the-art equipment and flexible terms to support your science-based startup today.

Learn more

Customized Support

Innovation Space provides critical support elements required to accelerate science-based startups to commercialization.

Learn more

Funding & Programs

From Investment to Mentorship Events to Business Building Accelerator programs, the Innovation Space can help your startup thrive.

Learn more

What We’ll Be Listening for at IS:CleanTech

Clean technology and advanced materials companies do not scale in isolation.

Many of these trends are still evolving, particularly as companies navigate manufacturing scale-up, longer commercialization timelines, and increasingly complex funding environments.

One of the questions we’re especially interested in exploring at IS:CleanTech is how founders, investors, corporate partners, and ecosystem leaders are adapting their strategies in response.

Where are companies finding momentum despite tighter capital conditions?

How are commercialization timelines changing?

What does operational readiness look like earlier in a company’s development?

And how are partnerships evolving as technologies move closer to market?

Strong science remains essential, but the companies gaining traction today are increasingly pairing technical innovation with disciplined execution, strategic partnerships, and infrastructure designed to support long-term growth.

We expect many of the most valuable insights at this year’s summit will come directly from the people actively building, funding, testing, and scaling these technologies in real time.